Pine Valley Investments’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.98M Buy
54,242
+141
+0.3% +$16.5K 0.28% 87
2026
Q1
$6.52M Buy
54,101
+701
+1% +$80.9K 0.3% 87
2025
Q4
$5.63M Buy
53,400
+351
+0.7% +$32.9K 0.26% 95
2025
Q3
$4.47M Buy
53,049
+726
+1% +$59.8K 0.22% 108
2025
Q2
$4.15M Buy
52,323
+3,538
+7% +$281K 0.23% 111
2025
Q1
$4.39M Sell
48,785
-1,297
-3% -$121K 0.27% 100
2024
Q4
$5M Sell
50,082
-472
-0.9% -$48.7K 0.3% 81
2024
Q3
$5.75M Sell
50,554
-1,454
-3% -$173K 0.35% 69
2024
Q2
$6.45M Buy
52,008
+2,024
+4% +$261K 0.42% 60
2024
Q1
$6.61M Sell
49,984
-1,608
-3% -$198K 0.44% 53
2023
Q4
$5.64M Buy
51,592
+2,633
+5% +$273K 0.41% 53
2023
Q3
$5.06M Buy
48,959
+4,441
+10% +$479K 0.46% 52
2023
Q2
$5.15M Buy
44,518
+20,208
+83% +$2.29M 0.5% 52
2023
Q1
$2.35M Buy
+24,310
New +$2.62M 0.35% 66

Other funds holding MRK

Pine Valley Investments's MRK Position: Q2 2026 in Review

Pine Valley Investments increased its Merck (MRK) stake by 0.26% in Q2 2026, buying an estimated $16.5K and bringing the position to 54,242 shares worth $6.98M. The position accounts for 0.28% of the portfolio, ranked #87.

Pine Valley Investments first reported a position in MRK in Q1 2023 and has held it in 14 quarters since. 2,218 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Pine Valley Investments held 54,242 shares of Merck worth $6.98M as of Q2 2026.
  • Pine Valley Investments bought 141 Merck shares in Q2 2026, an estimated $16.5K.
  • Merck made up 0.28% of Pine Valley Investments's portfolio in Q2 2026, its #87 holding.
  • Pine Valley Investments first reported a position in Merck in Q1 2023 and has held it in 14 quarters since.
  • 2,218 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Pine Valley Investments's 13F filing for Q2 2026, filed 24 Jul 2026.